Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.64 |
| ▸ | GRM5 | P41594 | 13/20 | 0.53 |
| ▸ | AVPR1A | P37288 | 2/20 | 0.46 |
| ▸ | PHGDH | O43175 | 1/20 | 0.46 |
| ▸ | CLK1 | P49759 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24937790 | 0.82 | AKR1C3 (0.62) | AKR1C3GRM5 | |
| SCHEMBL24937183 | 0.81 | AKR1C3 (0.65) | AKR1C3GRM5 | |
| SCHEMBL24937187 | 0.80 | AKR1C3 (0.60) | AKR1C3GRM5AVPR1APHGDHCLK1 | |
| SCHEMBL23777678 | 0.79 | AKR1C3 (0.66) | AKR1C3GRM5 | |
| SCHEMBL21432539 | 0.78 | AKR1C3 (1.00) | AKR1C3 | |
| SCHEMBL24937195 | 0.75 | NPC1 (0.67) | — | |
| SCHEMBL1904905 | 0.75 | AKR1C3 (0.61) | AKR1C3GRM5 | |
| SCHEMBL1903214 | 0.75 | GRM5 (0.64) | AKR1C3GRM5 | |
| SCHEMBL12781995 | 0.74 | TSHR (0.70) | AKR1C3GRM5 | |
| SCHEMBL24937791 | 0.72 | AKR1C3 (0.46) | AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | THE UNIVERSITY OF TOKYO (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230024778-A1 | STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND | UTS2R, TAS1R1, ULK3 | AKR1C3 689/4885GRM5 511/4885AVPR1A 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.